Therefore, it is not surprising to detect recurrent ATRX/DAXX mutations and ALT, which are factors known to correlate with worse prognosis and distant metastasis in functioning (insulinomas) as well as in non-functioning PanNETs [8, 11]. The gene discussed is ATRX; the disease is pancreatic insulinoma.